These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6680533)

  • 1. Arteriosclerosis obliterans in Japanese diabetic patients.
    Matsuda A; Kuzuya T
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():569-73. PubMed ID: 6680533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arteriosclerosis obliterans(ASO) in diabetic patients].
    Tanaka Y
    Nihon Rinsho; 2003 Jul; 61(7):1187-93. PubMed ID: 12877083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of hyperlipemia, hyperuricemia, diabetes mellitus, hypertension and overweight in arterial obliterating disease].
    Wollenweber J; Doenecke P; Greten H; Hild R; Nobbe F; Schmidt FH; Wagner E
    Dtsch Med Wochenschr; 1971 Jan; 96(3):103-7. PubMed ID: 5539511
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical features and treatment of arteriosclerosis obliterans with diabetes.
    Tsushima N; Matsuo H; Hayashi T; Homma S
    Diabetes; 1996 Jul; 45 Suppl 3():S101-4. PubMed ID: 8674871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of arteriosclerosis obliterans (ASO)].
    Matsuo H
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes and arteriopathies].
    Martorell A
    Angiologia; 1987; 39(1):36-41. PubMed ID: 3565847
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ultrasonographic findings of carotid arteries in female patients with arteriosclerosis obliterans and aortic aneurysm].
    Kin K; Iwamoto T; Koyama T; Sugiyama T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):239-44. PubMed ID: 10879074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arteriosclerosis obliterans (ASO)].
    Koshikawa M; Ikeda U
    Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of risk factors in arteriosclerosis obliterans of the lower extremities. Preliminary results].
    Forest JC; Clavel F; Côte J; Guidoin R; Gosselin C
    Union Med Can; 1981 Aug; 110(8):715-9. PubMed ID: 7292803
    [No Abstract]   [Full Text] [Related]  

  • 11. Involvement of MicroRNA-133a in the Development of Arteriosclerosis Obliterans of the Lower Extremities via RhoA Targeting.
    Li Y; Ouyang M; Shan Z; Ma J; Li J; Yao C; Zhu Z; Zhang L; Chen L; Chang G; Wang S; Wang W
    J Atheroscler Thromb; 2015; 22(4):424-32. PubMed ID: 25445891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors in arterial occlusion of the limbs.
    Widmer LK; Hartmann G; Duchosal F; Piechl SC
    Ger Med Mon; 1969 Oct; 14(10):476-9. PubMed ID: 5364343
    [No Abstract]   [Full Text] [Related]  

  • 13. Atherosclerosis obliterans of the lower extremities in Thai patients.
    Mutirangura P; Ruangsetakit C; Wongwanit C; Sermsathanasawadi N; Chinsakchai K
    J Med Assoc Thai; 2006 Oct; 89(10):1612-20. PubMed ID: 17128835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hazard factors of peripheral arterial occlusive diseases of different severity].
    Preuss EG; Eder H; Weller P
    Z Gesamte Inn Med; 1970 May; 25(10):464-8. PubMed ID: 5523563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetic arteriopathy. A new nosological entity between diabetic microangiopathy and atherosclerosis in diabetes].
    Pratesi F; Caramelli L
    Minerva Med; 1971 Jan; 62(9):390-1. PubMed ID: 5545797
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathology of arteriosclerosis obliterans].
    Hosoda Y
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):471-5. PubMed ID: 8808806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and arteriosclerosis obliterans in patients with NIDDM.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Nov; 20(11):1738-43. PubMed ID: 9353618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking and arteriosclerosis obliterans: an epidemiologic approach.
    Weiss NS
    Am J Epidemiol; 1972 Jan; 95(1):17-25. PubMed ID: 5007359
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics and survival in end-stage renal disease patients with arteriosclerosis obliterans.
    Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kawano Y
    Am J Nephrol; 2002; 22(5-6):422-8. PubMed ID: 12381939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arteriosclerosis obliterans-like vascular changes in diabetes mellitus].
    Kowalska M; Siciński A
    Pol Arch Med Wewn; 1966; 36(6):793-6. PubMed ID: 5911403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.